![Robert Lutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lutz
Consultant / Adviseur bij
ShangPharma Innovation, Inc.
Profiel
Robert Lutz is currently an Executive-in-Residence at ShangPharma Innovation, Inc. He was previously a VP-Translational Research & Development at ImmunoGen, Inc. from 1992 to 2015.
He received a doctorate degree from Brandeis University in 1987 and an undergraduate degree from the University of New Hampshire in 1981.
Actieve functies van Robert Lutz
| Bedrijven | Functie | Begin |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consultant / Adviseur | - |
Eerdere bekende functies van Robert Lutz
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01-04-2015 |
Opleiding van Robert Lutz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
72
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
